Abstract
Schizophrenia is a prevalent mental illness with a high societal burden, complex pathophysiology, and diverse genetic and environmental etiology. Its complexity, polygenicity, and heterogeneity have hindered mechanistic elucidation and the search for new therapeutics. We present a single-cell dissection of schizophrenia-associated transcriptomic changes in the human prefrontal cortex across two independent cohorts, one deeply profiling 48 subjects (361,996 cells), and the other broadly profiling 92 subjects (106,761 cells). We identified 25 cell types that we used to produce a high-resolution atlas of schizophrenia-altered genes and pathways. Excitatory neurons were the most affected cell group, with transcriptional changes converging on neurodevelopment and synapse-related molecular pathways. Differentially expressed gene sets implicate a coherently expressed module of trans-acting regulatory factors involved in neurodevelopment and genetically associated with schizophrenia risk. Transcriptional alterations significantly overlapped with known genetic risk factors, suggesting convergence of rare and common genomic variants on reproducible neuronal population specific alterations in schizophrenia. The severity of transcriptional pathology segregated two populations of schizophrenia subjects in a manner consistent with the expression of specific transcriptional patterns marked by genes involved in synaptic function and chromatin dynamics. Our results provide a high-resolution single cell atlas linking transcriptomic changes within specific cell populations to etiological genetic risk factors, contextualizing established knowledge within the cytoarchitecture of the human cortex and facilitating mechanistic understanding of schizophrenia pathophysiology and heterogeneity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Wilf Family Foundations and by NIH grant K08MH109759 (W.B.R.), by NIH grant K08MH122911 (G.V.), by NIH grant HHSN271201300031C (V.H.), by NIH grants R01AG050986, R01MH109677, U01MH116442, R01MH110921, R01MH125246 and R01AG067025 and the Veterans Affairs Merit grant BX002395 (P.R), and by NIH grants 1U01MH119509, R01MH109978, and R01AG062335 (M.K.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Postmortem human prefrontal cortex tissue from schizophrenia subjects and healthy control individuals matched for age and postmortem interval and including both sexes was obtained from two National Institute of Mental Health Neurobiobank associated tissue repositories, the Harvard Brain Tissue Resource Center at McLean Hospital, and The Mount Sinai/JJ Peters VA Medical Center NIH Brain and Tissue Repository. Institutional review board approval was provided by the Mass General Brigham Institutional Review Board or the Icahn School of Medicine at Mount Sinai Institutional Review Board to the relevant tissue repository for the collection, storage, and distribution of brain tissue and de-identified clinical information for each case.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
The source data and processed datasets described in this manuscript are available via the PsychENCODE Knowledge Portal (https://psychencode.synapse.org/). The PsychENCODE Knowledge Portal is a platform for accessing data, analyses, and tools generated through grants funded by the National Institute of Mental Health (NIMH) PsychENCODE program. Data is available for general research use according to the following requirements for data access and data attribution: (https://psychencode.synapse.org/DataAccess). For access to content described in this manuscript see: https://www.synapse.org/#!Synapse:syn25922167
